In a 2003 JCI paper, our group reported evidence and posited that elevated levels of soluble fms-like tyrosine kinase 1 (sFLT1) secreted from the placenta acted as the putative “endothelial toxin” that drives the clinical syndrome of preeclampsia (3). Here, FLT1 is linked to preeclampsia.